Company / Income Tax
Bicara Therapeutics Inc. Income Tax History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$180.0K
FY2024
5-year range
$5.0K / $180.0K
FY2023-FY2024
Trend
+3500.0%
vs FY2023
Sector context
#99 of 204
Health Care
What the data says
At $180,000, Bicara Therapeutics Inc.'s income tax ranks #106 of 204 in the Health Care sector.
Based on SEC 10-K filings.
$180,000 in FY2024.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#106 of 204 in Health CareTop 51% of 204This company $180.0K Sector average $118.7M
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2024, income tax increased 3500.0% year-over-year.
- Ranks #99 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 11.58 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $180.0K | +3500.0% |
| FY2023 | $5.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026